NM_001165963.4:c.2791C>T
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_001165963.4(SCN1A):c.2791C>T(p.Arg931Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R931H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001165963.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN1A | ENST00000674923.1 | c.2791C>T | p.Arg931Cys | missense_variant | Exon 18 of 29 | NM_001165963.4 | ENSP00000501589.1 | |||
SCN1A | ENST00000303395.9 | c.2791C>T | p.Arg931Cys | missense_variant | Exon 17 of 28 | 5 | ENSP00000303540.4 | |||
SCN1A | ENST00000375405.7 | c.2758C>T | p.Arg920Cys | missense_variant | Exon 15 of 26 | 5 | ENSP00000364554.3 | |||
SCN1A | ENST00000409050.1 | c.2707C>T | p.Arg903Cys | missense_variant | Exon 15 of 26 | 5 | ENSP00000386312.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:3
The Arg931Cys missense variant in the SCN1A gene has been reported as a de novo variant in multiple patients with Dravet syndrome and other SCN1A-related disorders (Ohmori et al., 2002; Depienne et al., 2009; an external mutation database). This amino acid substitution is non-conservative, as a positively charged Arginine residue is replaced by an uncharged Cysteine residue, and the gain of a Cysteine could affect disulfide bond formation in the protein. Arg931Cys alters a highly conserved position in the pore loop between the S5 and S6 segments of the second transmembrane domain, and many other variants have been reported in this region of the protein. -
- -
- -
Severe myoclonic epilepsy in infancy Pathogenic:1Other:1
- -
- -
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 931 of the SCN1A protein (p.Arg931Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Dravet syndrome (PMID: 12083760, 18076640). In at least one individual the variant was observed to be de novo. This variant is also known as Arg921Cys. ClinVar contains an entry for this variant (Variation ID: 68598). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SCN1A protein function with a positive predictive value of 95%. This variant disrupts the p.Arg931 amino acid residue in SCN1A. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 25243660, 27231140, 28079314). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
SCN1A-related disorder Pathogenic:1
The SCN1A c.2791C>T variant is predicted to result in the amino acid substitution p.Arg931Cys. This variant has been reported, with many de novo occurrences, in multiple individuals with SCN1A-related disorders (Ohmori et al. 2002. PubMed ID: 12083760; Truty R et al. 2019. PubMed ID: 31440721; Gertler TS et al. 2019. PubMed ID: 31864146; Gall K et al. 2021. PubMed ID: 34469436; Jiang T et al. 2021. PubMed ID: 34489640; Chen C et al. 2022. PubMed ID: 35571373; Wyers et al. 2021. PubMed ID: 3344514). Alternate nucleotide changes affecting the same amino acid (p.Arg931Ser, p.Arg931His, p.Arg931Pro) have been reported in individuals with SCN1A-related disease and reported to be pathogenic (Do TT et al. 2017. PubMed ID: 28079314). The c.2791C>T (p.Arg931Cys) variant has not been reported in a large population database, indicating it is rare. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at